Search research articles
Contact Us
Filters
Showing results (1-10 of 53) with videos related to
Page
of 6
Sort By:
Recent Patents on CNS Drug Discovery
|
January 28, 2012
A survey of recent patents on CB2 agonists in the management of pain
Gabriele Murineddu, Battistina Asproni, Gerard A Pinna
Molecules (Basel, Switzerland)
|
April 30, 2021
Tricyclic Pyrazole-Based Compounds as Useful Scaffolds for Cannabinoid CB<sub>1</sub>/CB<sub>2</sub> Receptor Interaction
Battistina Asproni, Gabriele Murineddu, Paola Corona, et al.
Chemical & Pharmaceutical Bulletin
|
June 5, 2002
Synthesis and cytotoxic activities of pyrrole[2,3-d]pyridazin-4-one derivatives
Gabriele Murineddu, Giorgio Cignarella, Giorgio Chelucci, et al.
Recent Patents on CNS Drug Discovery
|
March 13, 2013
Different classes of CB2 ligands potentially useful in the treatment of pain
Gabriele Murineddu, Francesco Deligia, Antonio Dore, et al.
International Journal of Molecular Sciences
|
May 7, 2025
Therapeutic Potential of Tricyclic Pyridazinone-Based Molecules: An Overview
Battistina Asproni, Gérard A Pinna, Paola Corona, et al.
Bioorganic & Medicinal Chemistry
|
April 3, 2007
3-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}-6-substituted-3,6-diazabicyclo[3.1.1]heptanes as novel potent dopamine uptake inhibitors
Giovanni Loriga, Stefania Ruiu, Ilaria Manca, et al.
Journal of Medicinal Chemistry
|
November 2, 2016
Synthesis and Antineoplastic Evaluation of Novel Unsymmetrical 1,3,4-Oxadiazoles
Valentina Nieddu, Giansalvo Pinna, Irene Marchesi, et al.
Bioorganic & Medicinal Chemistry
|
November 20, 2010
Synthesis and SAR study of new phenylimidazole-pyrazolo[1,5-c]quinazolines as potent phosphodiesterase 10A inhibitors
Battistina Asproni, Gabriele Murineddu, Amedeo Pau, et al.
Bioorganic & Medicinal Chemistry
|
April 9, 2002
N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes as mu-opioid receptor agonists. Effects on mu-affinity of arylalkenyl chain modifications
Gérard A Pinna, Giorgio Cignarella, Giovanni Loriga, et al.
European Journal of Medicinal Chemistry
|
August 19, 2014
Tricyclic pyrazoles part 7. Discovery of potent and selective dihydrothienocyclopentapyrazole derived CB2 ligands
Giansalvo Pinna, Maria Michela Curzu, Antonio Dore, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 53) with videos related to
Sort By:
Page
of 6
Recent Patents on CNS Drug Discovery
|
January 28, 2012
A survey of recent patents on CB2 agonists in the management of pain
Gabriele Murineddu, Battistina Asproni, Gerard A Pinna
Molecules (Basel, Switzerland)
|
April 30, 2021
Tricyclic Pyrazole-Based Compounds as Useful Scaffolds for Cannabinoid CB<sub>1</sub>/CB<sub>2</sub> Receptor Interaction
Battistina Asproni, Gabriele Murineddu, Paola Corona, et al.
Chemical & Pharmaceutical Bulletin
|
June 5, 2002
Synthesis and cytotoxic activities of pyrrole[2,3-d]pyridazin-4-one derivatives
Gabriele Murineddu, Giorgio Cignarella, Giorgio Chelucci, et al.
Recent Patents on CNS Drug Discovery
|
March 13, 2013
Different classes of CB2 ligands potentially useful in the treatment of pain
Gabriele Murineddu, Francesco Deligia, Antonio Dore, et al.
International Journal of Molecular Sciences
|
May 7, 2025
Therapeutic Potential of Tricyclic Pyridazinone-Based Molecules: An Overview
Battistina Asproni, Gérard A Pinna, Paola Corona, et al.
Bioorganic & Medicinal Chemistry
|
April 3, 2007
3-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}-6-substituted-3,6-diazabicyclo[3.1.1]heptanes as novel potent dopamine uptake inhibitors
Giovanni Loriga, Stefania Ruiu, Ilaria Manca, et al.
Journal of Medicinal Chemistry
|
November 2, 2016
Synthesis and Antineoplastic Evaluation of Novel Unsymmetrical 1,3,4-Oxadiazoles
Valentina Nieddu, Giansalvo Pinna, Irene Marchesi, et al.
Bioorganic & Medicinal Chemistry
|
November 20, 2010
Synthesis and SAR study of new phenylimidazole-pyrazolo[1,5-c]quinazolines as potent phosphodiesterase 10A inhibitors
Battistina Asproni, Gabriele Murineddu, Amedeo Pau, et al.
Bioorganic & Medicinal Chemistry
|
April 9, 2002
N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes as mu-opioid receptor agonists. Effects on mu-affinity of arylalkenyl chain modifications
Gérard A Pinna, Giorgio Cignarella, Giovanni Loriga, et al.
European Journal of Medicinal Chemistry
|
August 19, 2014
Tricyclic pyrazoles part 7. Discovery of potent and selective dihydrothienocyclopentapyrazole derived CB2 ligands
Giansalvo Pinna, Maria Michela Curzu, Antonio Dore, et al.
Page
of 6